These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9610357)

  • 21. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis.
    Liu B; Lee KW; Anzo M; Zhang B; Zi X; Tao Y; Shiry L; Pollak M; Lin S; Cohen P
    Oncogene; 2007 Mar; 26(12):1811-9. PubMed ID: 16983336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures.
    Kamanga-Sollo E; Pampusch MS; White ME; Hathaway MR; Dayton WR
    Exp Cell Res; 2005 Nov; 311(1):167-76. PubMed ID: 16214131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
    Miyake H; Hara I; Yamanaka K; Muramaki M; Gleave M; Eto H
    Oncol Rep; 2005 Feb; 13(2):341-5. PubMed ID: 15643522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
    Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
    Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
    J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L; Fauconnet S; Lamielle F; Adessi GL
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2.
    Chatterjee S; Park ES; Soloff MS
    Int J Urol; 2004 Oct; 11(10):876-84. PubMed ID: 15479293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor alpha and interferon gamma--induced cell growth arrest is mediated via insulin-like growth factor binding protein-3.
    Katz J; Nasatzky E; Werner H; Le Roith D; Shemer J
    Growth Horm IGF Res; 1999 Jun; 9(3):174-8. PubMed ID: 10502453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling.
    Butt AJ; Martin JL; Dickson KA; McDougall F; Firth SM; Baxter RC
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1950-6. PubMed ID: 15070968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coculture inserts possess an intrinsic ability to alter growth regulation of human breast cancer cells.
    Perachiotti A; Darbre PD
    Exp Cell Res; 1994 Aug; 213(2):404-11. PubMed ID: 7519565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.
    Butt AJ; Fraley KA; Firth SM; Baxter RC
    Endocrinology; 2002 Jul; 143(7):2693-9. PubMed ID: 12072403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor binding protein-3 is secreted as a phosphoprotein by human breast cancer cells.
    Pattison ST; Fanayan S; Martin JL
    Mol Cell Endocrinol; 1999 Oct; 156(1-2):131-9. PubMed ID: 10612431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments.
    Grkovic S; O'Reilly VC; Han S; Hong M; Baxter RC; Firth SM
    Oncogene; 2013 May; 32(19):2412-20. PubMed ID: 22751133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3.
    MacDonald RG; Schaffer BS; Kang IJ; Hong SM; Kim EJ; Park JH
    J Gastroenterol Hepatol; 1999 Jan; 14(1):72-8. PubMed ID: 10029281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
    Baxter RC
    Mol Pathol; 2001 Jun; 54(3):145-8. PubMed ID: 11376125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.
    Martin JL; Baxter RC
    J Biol Chem; 1999 Jun; 274(23):16407-11. PubMed ID: 10347201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive selection of growth-inhibitory genes.
    Maines JZ; Sunnarborg A; Rogers LM; Mandavilli A; Spielmann R; Boyd FT
    Cell Growth Differ; 1995 Jun; 6(6):665-71. PubMed ID: 7669720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.
    Schedlich LJ; Young TF; Firth SM; Baxter RC
    J Biol Chem; 1998 Jul; 273(29):18347-52. PubMed ID: 9660801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGFBP-3: a cell fate pivot in cancer and disease.
    Johnson MA; Firth SM
    Growth Horm IGF Res; 2014 Oct; 24(5):164-73. PubMed ID: 24953254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.